Cargando…

Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing

A 69-year-old man was diagnosed with IgG λ-type multiple myeloma (MM), Stage II in October 2010. He was treated with one cycle of high-dose dexamethasone. After three cycles of bortezomib, the patient exhibited slow elevations in the free light-chain levels and developed a significant new increase o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikeda, Hiroshi, Ishiguro, Kazuya, Igarashi, Tetsuyuki, Aoki, Yuka, Hayashi, Toshiaki, Ishida, Tadao, Sasaki, Yasushi, Tokino, Takashi, Shinomura, Yasuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599646/ https://www.ncbi.nlm.nih.gov/pubmed/26491355 http://dx.doi.org/10.2147/OTT.S86515

Ejemplares similares

Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
por: Aoki, Yuka, et al.
Publicado: (2012)

Correction: Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
por: Aoki, Yuka, et al.
Publicado: (2013)

Model of translational cancer research in multiple myeloma
por: Yasui, Hiroshi, et al.
Publicado: (2012)

DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling
por: Ishiguro, Kazuya, et al.
Publicado: (2019)

Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report
por: Ishiguro, Kazuya, et al.
Publicado: (2020)

Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein
por: Ishiguro, Kazuya, et al.
Publicado: (2017)

Corrigendum to “Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer”
por: Idogawa, Masashi, et al.
Publicado: (2019)

Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer
por: Idogawa, Masashi, et al.
Publicado: (2019)

Assessment of the quality of DNA from various formalin-fixed paraffin-embedded (FFPE) tissues and the use of this DNA for next-generation sequencing (NGS) with no artifactual mutation
por: Einaga, Naoki, et al.
Publicado: (2017)

A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth
por: Mita, Hiroaki, et al.
Publicado: (2009)

Fledglings in p53 signaling network
por: Tokino, Takashi, et al.
Publicado: (2017)

Interferon-α/β and Anti-Fibroblast Growth Factor Receptor 1 Monoclonal Antibody Suppress Hepatic Cancer Cells In Vitro and In Vivo
por: Sasaki, Shigeru, et al.
Publicado: (2011)

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer
por: Maruyama, Reo, et al.
Publicado: (2008)

Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors
por: Niinuma, Takeshi, et al.
Publicado: (2017)

Clinical implications of next‐generation sequencing‐based panel tests for malignant ovarian tumors
por: Saotome, Keiko, et al.
Publicado: (2020)

A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer
por: Kumegawa, Kohei, et al.
Publicado: (2016)

Targeted sequencing reveals genetic variants associated with sensitivity of 79 human cancer xenografts to anticancer drugs
por: Udagawa, Chihiro, et al.
Publicado: (2018)

Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors
por: Kamimae, Seiko, et al.
Publicado: (2015)

Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy
por: Mitsuhashi, Kei, et al.
Publicado: (2015)

Developing next generation immunomodulatory drugs and their combinations in multiple myeloma
por: Thakurta, Anjan, et al.
Publicado: (2021)

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics
por: Yamamoto, Itaru, et al.
Publicado: (2017)

Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
por: Manzoni, Martina, et al.
Publicado: (2020)

Toxicity management strategies for next-generation novel therapeutics in multiple myeloma
por: Steinbach, Mary, et al.
Publicado: (2022)

VIRAL AND CELLULAR SURFACE ANTIGENS OF MURINE LEUKEMIAS AND MYELOMAS : SEROLOGICAL ANALYSIS BY IMMUNOELECTRON MICROSCOPY
por: Aoki, Tadao, et al.
Publicado: (1972)

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
por: Medina, Alejandro, et al.
Publicado: (2020)

The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway
por: Kurihara, Hiroyoshi, et al.
Publicado: (2016)

Whole-exome sequencing of 79 xenografts as a potential approach for the identification of genetic variants associated with sensitivity to cytotoxic anticancer drugs
por: Udagawa, Chihiro, et al.
Publicado: (2020)

Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
por: Igarashi, Yuka, et al.
Publicado: (2020)

UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells
por: Niinuma, Takeshi, et al.
Publicado: (2019)

Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan
por: Takahashi, Toshiaki, et al.
Publicado: (2023)

New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer
por: Imaoka, Hiroshi, et al.
Publicado: (2019)

A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors
por: Isosaka, Mai, et al.
Publicado: (2015)

TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells
por: Kai, Masahiro, et al.
Publicado: (2016)

Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells
por: Idogawa, Masashi, et al.
Publicado: (2014)

Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database
por: Handa, Hiroshi, et al.
Publicado: (2023)

DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes
por: Hatanaka, Yui, et al.
Publicado: (2021)

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
por: Yao, Qiumei, et al.
Publicado: (2019)

Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
por: Bolli, Niccolo, et al.
Publicado: (2020)

Genetic profile for suspected dysferlinopathy identified by targeted next-generation sequencing
por: Izumi, Rumiko, et al.
Publicado: (2015)

Generation of functional liver organoids on combining hepatocytes and cholangiocytes with hepatobiliary connections ex vivo
por: Tanimizu, Naoki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ohji2ngml7ij1ptsph1tj16d1